| 1 | [SID26664781] | Active | AbsAC35_uM | 0.0235 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity [AID652041, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | AbsAC35_uM | 0.0235 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity | | AID | 652041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID26664781] | Active | AbsAC35_uM | 0.0417 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity [AID652047, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | AbsAC35_uM | 0.0417 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID26664781] | Active | Potency | 0.1651 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 0.1651 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID26664781] | Active | Potency | 0.1995 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID26664781] | Active | IC50 | 0.2 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID26664781] | Active | IC50 | 0.2 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID26664781] | Active | Potency | 0.2332 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 0.2332 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID26664781] | Active | Potency | 0.3548 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 0.3548 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 9 | [SID26664781] | Active | Potency | 0.3548 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 0.3548 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 10 | [SID26664781] | Active | EC50 | 0.357 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | EC50 | 0.357 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 11 | [SID26664781] | Active | EC50 | 0.976 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | EC50 | 0.976 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID26664781] | Active | AC50 | 1.28 | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity [AID652116, Type: confirmatory] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | AC50 | 1.28 [uM] | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652116 | | BioAssay type | confirmatory | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 13 | [SID26664781] | Active | EC50 | 2.474 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | EC50 | 2.474 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID26664781] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID26664781] | Active | Potency | 5.6234 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 21 | [SID26664781] | Active | Potency | 5.6234 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 22 | [SID26664781] | Active | AbsAC1000_uM | 6.482 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | AbsAC1000_uM | 6.482 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 23 | [SID26664781] | Active | AC50 | 12.04 | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504941, Type: confirmatory] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | AC50 | 12.04 [uM] | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504941 | | BioAssay type | confirmatory | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 24 | [SID26664781] | Active | IC50 | 13.1 | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay [AID624383, Type: confirmatory] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | IC50 | 13.1 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay | | AID | 624383 | | BioAssay type | confirmatory | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 25 | [SID26664781] | Active | EC50 | 15.297 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast [AID1933, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | EC50 | 15.297 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast | | AID | 1933 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID26664781] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 27 | [SID26664781] | Active | EC50 | 17.081 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast [AID1934, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | EC50 | 17.081 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast | | AID | 1934 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID26664781] | Active | Potency | 25.1189 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 29 | [SID26664781] | Active | Potency | 25.1189 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 30 | [SID26664781] | Active | IC50 | 35.46 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | IC50 | 35.46 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 31 | [SID26664781] | Active | Potency | 39.8107 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 32 | [SID26664781] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 33 | [SID26664781] | Active | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 34 | [SID26664781] | Active | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 35 | [SID26664781] | Active | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID26664781] | Active | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID26664781] | Active | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID138948] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID138948] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID330, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 330 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID138948] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 138948 | | CID | 319089 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID26664781] | Active | | | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. [AID1486, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. | | AID | 1486 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID26664781] | Active | | | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability [AID488956, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability | | AID | 488956 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID26664781] | Active | | | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435003, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435003 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID26664781] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 50 | [SID26664781] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26664781 | | CID | 319089 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|